Status:
COMPLETED
MK0476 Study in Adult Patients With Acute Asthma (0476-322)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
15-65 years
Phase:
PHASE3
Brief Summary
This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.
Eligibility Criteria
Inclusion
- Adult Patients With Acute Asthma Attacks
Exclusion
- Patient Has Any Known Or Suspected, Acute Or Chronic Cause For Their Pulmonary Symptoms Other Than Asthma (E.G., Copd, Chronic Heart Failure, Etc.)
- Patient Has A Smoking History (20 Cigarettes Per Day) Of More Than 15 Years
- Patient Has A Disease Of The Cardiovascular, Hepatic, Renal, Hematologic Systems, Or Other Severe Disease
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT00229970
Start Date
September 1 2005
End Date
June 1 2007
Last Update
February 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.